BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee-Tsai YL, Luna-Santiago R, Demichelis-Gómez R, Ponce-de-León A, Ochoa-Hein E, Tamez-Torres KM, Bourlon MT, Bourlon C. Determining the risk factors associated with the development of Clostridium difficile infection in patients with hematological diseases. Blood Res 2019;54:120-4. [PMID: 31309090 DOI: 10.5045/br.2019.54.2.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 De-la-rosa-martinez D, Rivera-buendía F, Cornejo-juárez P, García-pineda B, Nevárez-luján C, Vilar-compte D. Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in Mexico. American Journal of Infection Control 2022. [DOI: 10.1016/j.ajic.2022.02.011] [Reference Citation Analysis]
2 Yepez Guevara EA, Aitken SL, Olvera AV, Carlin L, Fernandes KE, Bhatti MM, Garey KW, Adachi J, Okhuysen PC. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes. Clin Infect Dis 2021;72:e460-5. [PMID: 32803229 DOI: 10.1093/cid/ciaa1184] [Reference Citation Analysis]